Literature DB >> 26194331

Protective effect of Blumea lacera DC aerial parts in indomethacin-induced enterocolitis in rats.

Santosh Basnet1, Ashish Adhikari2, Vijaya Kumar Sachidananda3, Boreddy Shivanandappa Thippeswamy4, Veeresh Prabhakar Veerapur5.   

Abstract

Traditionally Blumea lacera DC is used to treat inflammation and bowel ailments. Lack of specific, curative treatment for IBD enticed us to investigate the therapeutic efficacy of ethanolic extract of aerial parts of Blumea lacera DC (EEBL) against indomethacin-induced enterocolitis. Male Wistar rats were divided into six groups (n = 5) and different doses of EEBL (100 and 200 mg/kg, p.o) and sulphasalazine (100 mg/kg, p.o) were administered for seven days. Enterocolitis was induced by two subsequent doses of indomethacin (7.5 mg/kg, s.c) on 7th and 8th day. Treatments were continued up to 12th day and sacrificed. The protective effect was assessed on the basis of macroscopic scores of ileum strips, changes in biochemical parameters such as serum lactate dehydrogenase (LDH), tissue myeloperoxidase (MPO), lipid peroxidation (LPO), and total thiols (TT). Further, activity was ascertained by histopathological evaluations. HPLC fingerprinting profiling of EEBL was also carried out. Pre-treatment with EEBL or sulphasalazine significantly attenuated the indomethacin-induced proximal ileal damage, elevated levels of serum LDH, tissue MPO, LPO and lower levels of TT. Further, observed activity of EEBL was well correlated with histopathological alterations. The results revealed the protective action of the title plant against the indomethacin-induced enterocolitis in rats, which might be attributed by its antioxidant, anti-inflammatory, antimicrobial, and membrane-stabilizing properties.

Entities:  

Keywords:  Antioxidant; Blumea lacera; Crohn’s disease; HPLC; Inflammation; Inflammatory bowel disease

Mesh:

Substances:

Year:  2015        PMID: 26194331     DOI: 10.1007/s10787-015-0243-2

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  20 in total

Review 1.  Treatment of inflammatory bowel disease: safety and tolerability issues.

Authors:  Fernando Navarro; Stephen B Hanauer
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

2.  Protective effect of embelin against acetic acid induced ulcerative colitis in rats.

Authors:  Boreddy Shivanandappa Thippeswamy; Sekar Mahendran; Mahantesh I Biradar; Pooja Raj; Kamya Srivastava; Shrishailappa Badami; Veeresh Prabhakar Veerapur
Journal:  Eur J Pharmacol       Date:  2010-12-24       Impact factor: 4.432

3.  Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats.

Authors:  Hanan H Hagar; Azza El-Medany; Eman El-Eter; Maha Arafa
Journal:  Eur J Pharmacol       Date:  2006-10-13       Impact factor: 4.432

Review 4.  Glutathione metabolism and its selective modification.

Authors:  A Meister
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

Review 5.  Beyond cholesterol-lowering effects of plant sterols: clinical and experimental evidence of anti-inflammatory properties.

Authors:  Rgia A Othman; Mohammed H Moghadasian
Journal:  Nutr Rev       Date:  2011-06-30       Impact factor: 7.110

6.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

7.  Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.

Authors:  Akiko Tanaka; Shoko Hase; Tohru Miyazawa; Ryoko Ohno; Koji Takeuchi
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

Review 8.  Experimental models of inflammatory bowel disease.

Authors:  Antoni Stadnicki; Robert W Colman
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2003       Impact factor: 4.291

9.  Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats.

Authors:  Salim S Al-Rejaie; Hatem M Abuohashish; Maher M Al-Enazi; Abdullah H Al-Assaf; Mihir Y Parmar; Mohammed M Ahmed
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

10.  Mechanisms of acute and chronic intestinal inflammation induced by indomethacin.

Authors:  T Yamada; E Deitch; R D Specian; M A Perry; R B Sartor; M B Grisham
Journal:  Inflammation       Date:  1993-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.